ABSCI CORPORATION Share Price Today: Live Updates & Key Insights

ABSCI CORPORATION share price today is $8.95, up 7.59%. The stock opened at $8.58 against the previous close of $8.3, with an intraday high of $8.965 and low of $8.49.

ABSCI CORPORATION Share Price Chart

ABSCI CORPORATION

us-stock
To Invest in {{usstockname}}
us-stock

ABSCI CORPORATION Share Price Performance

$8.95 0.0759(7.59%) ABSI at 10 Aug 2026 05:44 PM Biotechnology
Lowest Today 8.49
Highest Today 8.965
Today’s Open 8.58
Prev. Close 8.3
52 Week High 12.06
52 Week Low 2.24
Day’s Range: Low 8.49 High 8.965
52-Week Range: Low 2.24 High 12.06
1 day return -
1 Week return +12.59
1 month return -21.98
3 month return +54.8
6 month return +223.32
1 year return +214.23
3 year return +413.79
5 year return -67.4
10 year return -

ABSCI CORPORATION Institutional Holdings

FMR Inc 13.31

ARK Investment Management LLC 8.10

BlackRock Inc 6.64

ARK Genomic Revolution ETF 6.20

Fidelity Growth Compy Commingled Pl S 6.12

ARK Genomic Revolution 6.04

Redmile Group, LLC 4.87

Fidelity Growth Company Fund 4.67

State Street Corp 4.32

Vanguard Capital Management, LLC 3.48

Advanced Micro Devices Inc 3.37

State Street® SPDR® S&P® Biotech ETF 3.00

Vanguard Morn Total Stk Mkt Idx Investor 2.60

iShares Russell 2000 ETF 2.11

Geode Capital Management, LLC 1.97

Woodline Partners LP 1.95

Ameriprise Financial Inc 1.88

ARK Venture D 1.78

Two Sigma Investments LLC 1.71

Columbia Acorn Inst 1.71

Fidelity Growth Company K6 1.46

Columbia Small Cap Growth 1.34

Columbia Small Cap Growth Inst 1.34

Gem Investment Advisors, LLC 1.28

Fidelity Series Growth Company 1.26

Baker Bros Advisors LP 1.26

Parkman Healthcare Partners LLC 1.10

Siren, L.L.C. 1.06

Massachusetts Financial Services Company 1.02

UBS Group AG 0.94

Fidelity Select Biotechnology 0.93

Vanguard Institutional Extnd Mkt Idx Tr 0.93

Fidelity Small Cap Index 0.81

Amova Asset Management Americas, Inc 0.80

Sumitomo Mitsui Trust Group Inc 0.80

Marshall Wace Asset Management Ltd 0.72

iShares Russell 2000 Growth ETF 0.62

Nuveen Quant Small Cap Equity R6 0.59

iShares Biotechnology ETF 0.58

US Small-Cap Growth II Equity Comp 0.53

ABSCI CORPORATION Market Status

Strong Buy: 5

Buy: 4

Hold: 0

Sell: 0

Strong Sell: 0

ABSCI CORPORATION Fundamentals

Market Cap 1406.02 M

PB Ratio 7.6686

PE Ratio 0.0

Enterprise Value 1197.49 M

Total Assets 216.30 M

Volume 2193535

ABSCI CORPORATION Company Financials

Annual Revenue FY23:6937000 6.9M, FY22:5747000 5.7M, FY21:4782000 4.8M, FY20:4780000 4.8M, FY19:2060000 2.1M

Annual Profit FY23:null 0.0M, FY22:5747000 5.7M, FY21:4782000 4.8M, FY20:4780000 4.8M, FY19:2060000 2.1M

Annual Net worth FY23:-106492000 -106.5M, FY22:-104904000 -104.9M, FY21:-100960000 -101.0M, FY20:-14569000 -14.6M, FY19:-6801000 -6.8M

Quarterly Revenue Q1/2026:215000 0.2M, Q3/2025:378000 0.4M, Q2/2025:593000 0.6M, Q1/2025:1179000 1.2M, Q3/2024:1701000 1.7M

Quarterly Profit Q1/2026:-2513000 -2.5M, Q3/2025:378000 0.4M, Q2/2025:-19865000 -19.9M, Q1/2025:-15185000 -15.2M, Q3/2024:1701000 1.7M

Quarterly Net worth Q1/2026:-29599000 -29.6M, Q3/2025:-28706000 -28.7M, Q2/2025:-30569000 -30.6M, Q1/2025:-26346000 -26.3M, Q3/2024:-27398000 -27.4M

About ABSCI CORPORATION & investment objective

Company Information Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Organisation Biotechnology

Employees 140

Industry Biotechnology

CEO Mr. Sean McClain

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

ABSCI CORPORATION FAQs

What is the share price of ABSCI CORPORATION today?

The current share price of ABSCI CORPORATION is $8.95.

Can I buy ABSCI CORPORATION shares in India?

Yes, Indian investors can buy ABSCI CORPORATION shares by opening an international trading and demat account with Motilal Oswal.

How to buy ABSCI CORPORATION shares in India?

You can easily invest in ABSCI CORPORATION shares from India by:

Can I buy fractional shares of ABSCI CORPORATION?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ABSCI CORPORATION?

ABSCI CORPORATION has a market cap of $1406.02 M.

In which sector does ABSCI CORPORATION belong?

ABSCI CORPORATION operates in the Biotechnology sector.

What documents are required to invest in ABSCI CORPORATION stocks?

To invest, you typically need:

What is the PE and PB ratio of ABSCI CORPORATION?

The PE ratio of ABSCI CORPORATION is N/A and the PB ratio is 7.67.